Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice.
Salaymeh Y, Farago M, Sebban S, Shalom B, Pikarsky E, Katzav S. Salaymeh Y, et al. Among authors: shalom b. Life Sci Alliance. 2020 Apr 10;3(5):e202000661. doi: 10.26508/lsa.202000661. Print 2020 May. Life Sci Alliance. 2020. PMID: 32277014 Free PMC article.
Vav1 mutations: What makes them oncogenic?
Farago M, Yarnitzky T, Shalom B, Katzav S. Farago M, et al. Among authors: shalom b. Cell Signal. 2020 Jan;65:109438. doi: 10.1016/j.cellsig.2019.109438. Epub 2019 Oct 22. Cell Signal. 2020. PMID: 31654719 Free article. Review.
Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes.
Shalom B, Farago M, Pikarsky E, Katzav S. Shalom B, et al. Oncogenesis. 2018 Oct 8;7(10):80. doi: 10.1038/s41389-018-0091-1. Oncogenesis. 2018. PMID: 30297765 Free PMC article.
Ibera C, Shalom B, Saifi F, Shruder J, Davidson E. Ibera C, et al. Among authors: shalom b. Harefuah. 2018 Mar;157(3):162-166. Harefuah. 2018. PMID: 29582946 Clinical Trial. Hebrew.
Soluble factors from multipotent mesenchymal stromal cells have antinecrotic effect on cardiomyocytes in vitro and improve cardiac function in infarcted rat hearts.
Fidelis-de-Oliveira P, Werneck-de-Castro JP, Pinho-Ribeiro V, Shalom BC, Nascimento-Silva JH, Costa e Souza RH, Cruz IS, Rangel RR, Goldenberg RC, Campos-de-Carvalho AC. Fidelis-de-Oliveira P, et al. Among authors: shalom bc. Cell Transplant. 2012;21(5):1011-21. doi: 10.3727/096368911X623916. Epub 2012 Feb 2. Cell Transplant. 2012. PMID: 22305373 Free article.